Value-based approach to US drug spend needed

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.446, 2004-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US prescription drug spend up 19%

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 314, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pipeline drugs influence future US drug spend

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 335, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

US Medicare drug spend set to increase, stiffly criticised

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Value-Based Pricing: Examples of Healthcare System Reforms from the UK and US and Implications for Industry

By Miller David W.

Pharmaceutical Medicine, Vol. 26, Iss. 4, 2012-08 ,pp. : 217-222

Adis International

Access to resources Recommend Favorite

Value-based pricing hot at ISPOR

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite